Package 75826-134-10

{"route": ["ORAL"], "spl_id": "3de77685-67e3-815d-e063-6394a90a0fdb", "openfda": {"upc": ["0375826134100"], "unii": ["MFM6K1XWDK", "91ZQW5JF1Z"], "rxcui": ["889614"], "spl_set_id": ["87d1a147-d3c3-4097-aac0-4b19c49eabe3"], "manufacturer_name": ["Winder Laboratories LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE, PLASTIC (75826-134-10)", "package_ndc": "75826-134-10", "marketing_start_date": "20201207"}], "brand_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "product_id": "75826-134_3de77685-67e3-815d-e063-6394a90a0fdb", "dosage_form": "CAPSULE", "pharm_class": ["Anticholinergic [EPC]", "Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cholinergic Antagonists [MoA]", "Decreased Parasympathetic Acetylcholine Activity [PE]", "Digestive/GI System Activity Alteration [PE]", "GI Motility Alteration [PE]"], "product_ndc": "75826-134", "dea_schedule": "CIV", "generic_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "labeler_name": "Winder Laboratories LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "active_ingredients": [{"name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "CLIDINIUM BROMIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA212344", "marketing_category": "ANDA", "marketing_start_date": "20201207", "listing_expiration_date": "20271231"}